Moderna (NasdaqGS:MRNA) appointed Juan Andres as its first Chief Operating Officer as it reshapes its leadership structure.

Moderna (NASDAQ:MRNA) stock is in focus as cancer-vaccine optimism and a pending Nasdaq-100 addition anchor the mRNA developer's healthcare headlines today.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The big catalyst that seemed to boost Moderna's stock came around mid-June, when there was positive news about its seasonal influenza vaccine, mRNA-1010; an FDA advisory committee voted in favor of ...

Will the "cancer vaccine" become a leading player that surpasses Keytruda?On August 19, 2026, Moderna and Merck announced ...

Post-pandemic, investors bailed on what was once one of the most-followed biotech stocks amid pessimism about the company's ability to further monetize its mRNA technology. But then, as the company ...

Warner Bros. Discovery drops from Nasdaq 100 and S&P 500 as $81B Paramount merger closes. Moderna and Twilio fill the vacancies next week.